Australia's Imricor rises as Q1 revenue sees near fourfold jump
Shares of Imricor IMR.AX rise 5.71% to A$1.48, their biggest intraday pct gain since April 11
The medical device developer says its consumables revenue in Q1 up 385% Y-O-Y at $104,000
Stock hits its highest level since April 16
Stock up 8.82% this year, including the day's move
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Intel Foundry Gains ‘High-Profile’ Customer, Tesla Becomes First Major Customer for 14A Technology

Anthropic Eclipses OpenAI in Secondary Market as Valuation Hits $1 Trillion Milestone, Is the AI Market Overheating Now?

Intel Better-Than-Expected Earnings Released, Stock Surges 20% After-Hours, AI Computing Power Enters CPU Moment?

Semiconductor Sector Continues to Rise, Should Retail Investors Buy Intel or AMD?
Nebius Stock: Can This AI Infrastructure Play Really Double in 2026?

Tradingkey








